BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6758236)

  • 1. New approaches to the use of antibodies for immunosuppression.
    Russell PS
    Transplant Proc; 1982 Sep; 14(3):506-8. PubMed ID: 6758236
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and therapeutic applications of monoclonal antibodies to human T-cell subsets in renal transplant recipients.
    Cosimi AB
    Urol Clin North Am; 1983 May; 10(2):289-99. PubMed ID: 6344388
    [No Abstract]   [Full Text] [Related]  

  • 3. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 4. Xenotransplantation from pig to cynomolgus monkey: approach toward tolerance induction.
    Latinne D; Gianello P; Smith CV; Nickeleit V; Kawai T; Beadle M; Haug C; Sykes M; Lebowitz E; Bazin H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):336-8. PubMed ID: 8438325
    [No Abstract]   [Full Text] [Related]  

  • 5. Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary?
    Renlund DG; O'Connell JB; Bristow MR
    J Heart Transplant; 1989; 8(3):191-3. PubMed ID: 2661767
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibody.
    Bach JF; Dardenne M; Chatenoud L
    Transplant Proc; 1982 Sep; 14(3):509-12. PubMed ID: 6758237
    [No Abstract]   [Full Text] [Related]  

  • 7. Rejection prophylaxis with antilymphocyte globulin for cardiac transplantation in Oriental recipients.
    Wei J; Chang CY; Lee FY; Song YB; Jiau SF
    Transplant Proc; 1992 Aug; 24(4):1493-7. PubMed ID: 1496632
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
    Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F
    Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
    [No Abstract]   [Full Text] [Related]  

  • 9. Definition, diagnosis, and treatment of acute kidney rejection--the first 30 days.
    Howard RJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):92-103. PubMed ID: 2421468
    [No Abstract]   [Full Text] [Related]  

  • 10. Antirejection treatment in kidney transplantation--is there a proved rationale for the general use of monoclonal antibodies?
    Reis HJ; Hopt UT; Greger B; Schareck WD; Bockhorn H
    Transplant Proc; 1987 Oct; 19(5):3565-9. PubMed ID: 2823424
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined pancreas-kidney transplants using quadruple immunosuppression therapy: a comparison between antilymphoblast and antithymocyte globulins.
    Fasola CG; Hricik DE; Schulak JA
    Transplant Proc; 1995 Dec; 27(6):3135-6. PubMed ID: 8539880
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoclonal antibodies for kidney allograft rejection.
    Med Lett Drugs Ther; 1986 Oct; 28(724):97-8. PubMed ID: 3531791
    [No Abstract]   [Full Text] [Related]  

  • 14. Antilymphocyte serum for preventing graft rejection.
    Niblack GD; Johnson HK; Richie RE; Tallent MB; MacDonell R
    Proc Clin Dial Transplant Forum; 1980; 10():160-4. PubMed ID: 7050979
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibodies for the diagnosis and treatment of transplant rejection.
    Russell PS; Colvin RB; Cosimi AB
    Annu Rev Med; 1984; 35():63-81. PubMed ID: 6372674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
    de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of a monoclonal anti-T cell antibody vs ATG as prophylaxis after heart transplantation.
    Wollenek G; Laufer G; Laczkovics A; Buxbaum P; Kober I
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2499-501. PubMed ID: 2495642
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that initial T cell depletion suppresses antiantibody formation and preserves immunosuppression after polyclonal ATG.
    Thienfelder S; Hoffmann-Fezer G; Kremmer E
    Transplantation; 1989 Sep; 48(3):511-4. PubMed ID: 2571208
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
    Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
    Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of cellular events within stable and rejecting allografts in cynomolgus monkeys.
    Wee SL; Colvin RB; Stroka DM; Jolliffe LK; Cosimi AB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):821-3. PubMed ID: 1990702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.